Big Health Business Unit

Established in 2017, located in Beijing. It aims at large-scale research, development and production of genetic engineering antigens, monoclonal antibodies, polyclonal antibodies and other key materials for in vitro diagnosis of infectious diseases, infectious diseases, tumors, autoimmune diseases and cardiovascular and cerebrovascular diseases, providing research, development and production services for in vitro diagnostic enterprises, and providing high-quality raw materials and products for the development of immune diagnostic reagents.

The research institute is chaired by Professor Zhang Heqiu from the Institute of Basic Medicine of the former Academy of Military Medical Sciences and the National Immunodiagnostic Engineering Laboratory. It has a research and development team led by experts in the field of in vitro diagnosis, a professional technical and production team, and an experienced registration and application team. It can provide technical services such as innovative biomarker screening, high-quality antigen antibody research and development, large-scale production, and process optimization of new in vitro diagnostic products, And provide high-quality registration consulting services.